HANFORD SHUMAN: Open Payments
NPI 1013518828 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 29 payments from 7 companies in 2025. Trend: 2023 $348 · 2024 $373 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $207 |
| Novo Nordisk Inc | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, QULIPTA, Wegovy, CAPLYTA, AIRSUPRA, Auvelity, UBRELVY, ZEPBOUND.
Industry payments across UT — which companies pay providers there.
